Non-invasive evaluation of arterial abnormalities in hypertensive patients

被引:56
作者
Asmar, RG [1 ]
Topouchian, JA [1 ]
Benetos, A [1 ]
Sayegh, FA [1 ]
Mourad, JJ [1 ]
Safar, ME [1 ]
机构
[1] HOP BROUSSAIS, INSERM U337, F-75674 PARIS, FRANCE
关键词
arteries; hypertension; non-invasive techniques; arterial stiffness; haemodynamics; antihypertensive agents;
D O I
10.1097/00004872-199715022-00010
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
Arterial abnormalities in hypertension Morbidity and mortality in hypertension are mainly determined by arterial lesions which may occur in different regional circulations (e.g. kidney, cerebral, coronary circulations, causing nephroangiosclerosis, stroke or myocardial infarction, respectively), Despite arterial heterogeneity, structural and functional abnormalities are usually observed at an early stage of hypertension in both large and small arteries, These alterations modify physiological and mechanical properties of the arterial wall, which may become clinically evident by increasing arterial pulsatility or pulse pressure; the alterations facilitate the establishment and progression of atherosclerosis and arteriosclerosis. Methods of assessing arterial abnormalities Several noninvasive techniques can be used to assess haemodynamic properties of arteries: (1) casual and ambulatory blood pressure measurements can be used to evaluate pulse pressure; (2) pulse pressure can be measured directly in different sites of the arterial tree using the Tonometer device; (3) ultrasound techniques can be applied, including Doppler signals to assess the arterial flow, video-echo signals to analyse the arterial structure such as the intimal-medial thickness and echo-tracking systems far direct measurements of arterial wall distension and thickness;(4) pulse wave velocity is widely used as an index of arterial distensibility; this parameter, assessed by the Complier device, has shown that hypertensive patients have decreased arterial distensibility and that antihypertensive treatment does not always reverse this abnormality. Treatment It is important to evaluate the effect of cardiovascular risk-reduction measures on the arterial wall, Large therapeutic trials are necessary to show whether an evaluation of arterial abnormalities can identify patients with a high cardiovascular risk and contribute to their treatment and prognostic improvement.
引用
收藏
页码:S99 / S107
页数:9
相关论文
共 57 条
[1]
EVIDENCE FOR INCREASED MEDIA THICKNESS, INCREASED NEURONAL AMINE UPTAKE, AND DEPRESSED EXCITATION CONTRACTION COUPLING IN ISOLATED RESISTANCE VESSELS FROM ESSENTIAL HYPERTENSIVES [J].
AALKJAER, C ;
HEAGERTY, AM ;
PETERSEN, KK ;
SWALES, JD ;
MULVANY, MJ .
CIRCULATION RESEARCH, 1987, 61 (02) :181-186
[2]
[Anonymous], 1991, JAMA, V265, P3255
[3]
[Anonymous], 1994, Textbook of Hypertension
[4]
ARCARO G, 1991, J HYPERTENS, V9, P947
[5]
ARTERIAL STIFFNESS - A NEW CARDIOVASCULAR RISK FACTOR [J].
ARNETT, DK ;
EVANS, GW ;
RILEY, WA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (08) :669-682
[6]
ASSESSMENT OF ARTERIAL DISTENSIBILITY BY AUTOMATIC PULSE-WAVE VELOCITY-MEASUREMENT - VALIDATION AND CLINICAL-APPLICATION STUDIES [J].
ASMAR, R ;
BENETOS, A ;
TOPOUCHIAN, J ;
LAURENT, P ;
PANNIER, B ;
BRISAC, AM ;
TARGET, R ;
LEVY, BI .
HYPERTENSION, 1995, 26 (03) :485-490
[7]
ARTERIAL DISTENSIBILITY AND AMBULATORY BLOOD-PRESSURE MONITORING IN ESSENTIAL-HYPERTENSION [J].
ASMAR, RG ;
BRUNEL, PC ;
PANNIER, BM ;
LACOLLEY, PJ ;
SAFAR, ME .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (13) :1066-1070
[8]
ASMAR RG, 1994, J HYPERTENS, V12, P697
[9]
AMBULATORY BLOOD-PRESSURE MEASUREMENT, SMOKING AND ABNORMALITIES OF GLUCOSE AND LIPID-METABOLISM IN ESSENTIAL-HYPERTENSION [J].
ASMAR, RG ;
GIRERD, XJ ;
BRAHIMI, M ;
SAFAVIAN, A ;
SAFAR, ME .
JOURNAL OF HYPERTENSION, 1992, 10 (02) :181-187
[10]
REVERSION OF CARDIAC-HYPERTROPHY AND REDUCED ARTERIAL COMPLIANCE AFTER CONVERTING ENZYME-INHIBITION IN ESSENTIAL-HYPERTENSION [J].
ASMAR, RG ;
PANNIER, B ;
SANTONI, JP ;
LAURENT, S ;
LONDON, GM ;
LEVY, BI ;
SAFAR, ME .
CIRCULATION, 1988, 78 (04) :941-950